drugset / Trial / NCT00725270

Treatment of Schizoaffective Disorder Using Mifepristone

NCT00725270

RandomizedParallel-groupTriple-blindTreatment

Summary

This study tests the hypothesis that mifepristone will diminish cognitive distortion and alleviate psychosis in patients with schizoaffective disorder.

Timeline

Start
1998-04
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 600 mg